ID

14653

Description

Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00841113

Link

https://clinicaltrials.gov/show/NCT00841113

Keywords

  1. 4/25/16 4/25/16 -
Uploaded on

April 25, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Prostate Cancer NCT00841113

Eligibility Prostate Cancer NCT00841113

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically proven prostate cancer and not previously treated with hormones
Description

Prostate Cancer and its treatment

Data type

boolean

Alias
UMLS CUI [1]
C0600139
UMLS CUI [2,1]
C0332155
UMLS CUI [2,2]
C0279025
evidance of advanced disease or metastases
Description

Advanced disease or metastases

Data type

boolean

Alias
UMLS CUI [1]
C0679246
UMLS CUI [2]
C0027627
life expectancy of at least 3 months
Description

Life expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
normal serum testosterone levels
Description

Serum testosterone measurement

Data type

boolean

Alias
UMLS CUI [1]
C0428413
written informed consent
Description

Informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous endocrine or cytoxic theapy for prostate cancer
Description

Hormone therapy and chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0279025
UMLS CUI [2]
C0392920
known tumour complication of prostate cancer which owuld require immediate treatment
Description

Cancer complication

Data type

boolean

Alias
UMLS CUI [1]
C0596237
another malignancy other than basal cell cancer
Description

Further malignancy

Data type

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0332196
UMLS CUI [1,3]
C0007114
history of significant drug hypersensitivity to either lhrh agonists or gnrh antagonists.
Description

Allergies

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1518041
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C1268855
congenital or acquired coagulation disorders contraindicating intramuscular injections
Description

Coagulation disorder

Data type

boolean

Alias
UMLS CUI [1]
C0005779
pagets disease of the bone
Description

Pagets disease

Data type

boolean

Alias
UMLS CUI [1]
C0029401
qtcb > 450 msec at day - 14
Description

QTcB

Data type

boolean

Alias
UMLS CUI [1]
C1882512

Similar models

Eligibility Prostate Cancer NCT00841113

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Prostate Cancer and its treatment
Item
histologically proven prostate cancer and not previously treated with hormones
boolean
C0600139 (UMLS CUI [1])
C0332155 (UMLS CUI [2,1])
C0279025 (UMLS CUI [2,2])
Advanced disease or metastases
Item
evidance of advanced disease or metastases
boolean
C0679246 (UMLS CUI [1])
C0027627 (UMLS CUI [2])
Life expectancy
Item
life expectancy of at least 3 months
boolean
C0023671 (UMLS CUI [1])
Serum testosterone measurement
Item
normal serum testosterone levels
boolean
C0428413 (UMLS CUI [1])
Informed consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Hormone therapy and chemotherapy
Item
previous endocrine or cytoxic theapy for prostate cancer
boolean
C0279025 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
Cancer complication
Item
known tumour complication of prostate cancer which owuld require immediate treatment
boolean
C0596237 (UMLS CUI [1])
Further malignancy
Item
another malignancy other than basal cell cancer
boolean
C0006826 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0007114 (UMLS CUI [1,3])
Allergies
Item
history of significant drug hypersensitivity to either lhrh agonists or gnrh antagonists.
boolean
C0020517 (UMLS CUI [1,1])
C1518041 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C1268855 (UMLS CUI [2,2])
Coagulation disorder
Item
congenital or acquired coagulation disorders contraindicating intramuscular injections
boolean
C0005779 (UMLS CUI [1])
Pagets disease
Item
pagets disease of the bone
boolean
C0029401 (UMLS CUI [1])
QTcB
Item
qtcb > 450 msec at day - 14
boolean
C1882512 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial